Category: Biotechnology
Training our immune systems: Why we should insist on a high-quality COVID-19 vaccine
The way we train our immune systems now to respond to SARS-CoV-2 could impact how well our bodies can respond to future coronaviruses.
A Real Vaccine Before the Election? It’d Take a Miracle.
If you look at all the steps needed for a coronavirus vaccine to be scientifically validated and cleared for public use. tt’s a long shot in 38 days.
NIH ‘Very Concerned’ About Serious Side Effect in Coronavirus Vaccine Trial
A great deal of uncertainty remains about what happened to the unnamed patient, to the frustration of those avidly following the progress of vaccine testing.
5 Things to Know About Convalescent Blood Plasma
With all the news swirling around convalescent plasma, we thought we’d break it down for you.
Public Health Experts Fear a Hasty FDA Signoff on Vaccine
The agency must give outside scientists and the public the opportunity to see the data and the FDA’s reasoning before coming to such a decision, critics say.
‘Genomic fingerprinting’ helps us trace coronavirus outbreaks. What is it and how does it work?
Mapping the COVID-19 ‘family tree’
How — and When — Can the Coronavirus Vaccine Become a Reality?
It is likely we’ll eventually have a coronavirus vaccine — but perhaps not as quickly as some expect. From development, to clinical trials and distribution, there are tremendous challenges lying ahead.
UW study yields clues to how drug may boost aged mitochondria
Findings may help explain why these energy-producing cellular organelles begin to fail as we age.
Adding women to corporate boards improves decisions about medical product safety
Medical supply companies with boards that included at least two women recalled life-threatening products almost a month sooner than those with all-male boards,
The ABCs of drug trials
From the research lab to your doctor’s office – here’s what happens in phase 1, 2, 3 drug trials
Coronavirus: what is convalescent plasma therapy?
Convalescent plasma treatment involves using plasma from people who have recovered from COVID-19 and infusing it into patients who currently have the disease.
Analysis: The Real Tragedy Of Not Having Enough COVID-19 Tests
Knowing the result of a test allows rational individual decisions.
ISB and Swedish Launch Trial to Understand, Treat COVID-19
The study will follow patients who contract COVID-19 to learn why some die, some recover, and some are asymptomatic.
UW Medicine recruiting for app to predict next outbreak
The phone app could diagnose illness sooner, preventing members of the military and civilians who are ill from returning to work or school too soon.